All projects undertaken using data in the National Genomic Research Library are publicly listed in the Genomics England Research Registry. These projects exemplify the breadth of research and its ...

You can use the form below to sign up for email alerts about new positions as they open. Fields marked with an asterisk (*) are required. Genomics England is a global leader in enabling genomic ...

You can use the form below to sign up for email alerts about new positions as they open. Fields marked with an asterisk (*) are required. Genomics England is a global leader in enabling genomic ...

You can use the form below to sign up for email alerts about new positions as they open. Fields marked with an asterisk (*) are required. Genomics England is a global leader in enabling genomic ...

At Genomics England, we are committed to transforming health outcomes through innovation in genomics that benefit all patients, regardless of their background. Our Diverse Data Initiative is leading ...

In this episode of our explainer podcasts, we’ve asked Jamie Ellingford, Lead Genome Data Scientist for Rare Disease at Genomics England, to explain what bioinformaticians do and how they're involved ...

Will provide definitive diagnoses for more patients and uncover novel mechanisms of disease Consensus-based recommendations expand upon existing standards developed for gene panel and exome testing, ...

The pioneering Yellow Card Biobank, launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England, will today start investigating whether the risk of acute ...

Hundreds of babies have begun to be tested for over 200 rare genetic conditions as part of a world-leading study in NHS hospitals that aims to screen up to 100,000 newborns in England. The Generation ...

A boy born with a rare form of eye cancer, usually diagnosed in very young children, is one of numerous babies born with rare conditions who are receiving earlier diagnoses and faster, lifechanging ...

Study shows that combining whole genome sequence and clinical data together at scale supports the delivery of precision cancer care, where cancer diagnosis and treatment is tailored to the individual ...